Drug maker Novartis AG (NOVN.CH) is in advanced talks to acquire MorphoSys AG (MOR.DE), two people familiar with the matter told Reuters on Monday.
The sources added that there is no certainty that negotiations on the deal will be successful and asked to remain anonymous as the matter is confidential. They declined to provide any information on the acquisition price.
MorphoSys shares are currently gaining nearly 37%.

Source: xStation
Intel declines: Share in "Terra Fab" threaten?
Market Wrap: France’s Budget, Spain’s Elections. Politics Returns to the Markets
Schneider Electric pays a high price for AI and software growth
Morning wrap: Strong Wall Street, weak Europe and Asia 🚩 NFP to test equity strength